08/20/2026
The wider use of 8-aminoquinoline medicines such as primaquine and tafenoquine for P. vivax radical cure is creating an opportunity for diagnostic companies to combine malaria detection with G6PD testing.
SD BIOSENSOR 에스디바이오센서 has developed the STANDARD G6PD Test, a portable point-of-care test that quantitatively measures G6PD activity and hemoglobin from a finger-stick sample. It is specifically positioned to support safe use of primaquine and tafenoquine for P. vivax radical cure.
𝐆𝐞𝐭 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐨𝐧 𝐭𝐡𝐞 𝐞𝐯𝐨𝐥𝐯𝐢𝐧𝐠 𝐥𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞 𝐨𝐟 𝐦𝐚𝐥𝐚𝐫𝐢𝐚 𝐝𝐢𝐚𝐠𝐧𝐨𝐬𝐢𝐬:
https://straitsresearch.com/report/malaria-diagnostics-market